Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Conjugate or complex
Reexamination Certificate
1997-09-26
2001-06-26
Lankford, Jr., Leon B. (Department: 1651)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Conjugate or complex
C424S439000, C426S599000, C426S615000, C426S648000, C514S458000, C514S824000
Reexamination Certificate
active
06251400
ABSTRACT:
1. INTRODUCTION
The present invention relates to compositions and methods for the prevention and treatment of oncogenic disorders, atherosclerosis and hypercholesterolemia, with citrus limonoids, flavonoids and/or tocotrienols. Limonoids are a group of chemically related triterpene derivatives found in the Rutaceae and Meliaceae families. Citrus limonoids are among the bitter principles in citrus juices such as lemon, lime, orange and grapefruit. Flavonoids are polyphenolic compounds that occur unbiquitously in plant foods especially in orange, grapefruit and tangerine. Tocotrienols are present in palm oil and are a form of vitamin E having an unsaturated side chain. In the practice of the cancer prevention and/or treatment of the invention the limonoids, flavonoids and tocotrienols are used to inhibit the development and proliferation of cancer cells. Preferred compositions of the invention are those which specifically or preferentially prevent transformation of preneoplastic cells to tumor cells, and prevent or inhibit tumor cell proliferation, invasion and metastasis without general cytotoxic effects. In the practice of the prevention and/or treatment of atherosclerosis and/or hypercholesterolemia, the flavonoids, limonoids and tocotrienols are used to inhibit production of cholesterol, low-density lipoprotein (LDL) and apo B protein. Compositions comprising citrus flavonoids, limonoids and tocotrienols are used to prevent and/or inhibit production of cholesterol, LDL and apoB.
2. BACKGROUND
2.1. Citrus Limonoids
Limonoids are a group of chemically related triterpene derivatives found in the Rutaceae and Meliaceae families. Limonoids are among the bitter principles found in citrus fruits such as lemons, lime, orange and grapefruit. They are also present as glucose derivatives in mature fruit tissues and seed, and are one of the major secondary metabolites present in Citrus. Limonoids have been found to have anti-carcinogenic activity in laboratory animals. The furan moiety attached to the D-ring is specifically responsible for detoxifying of the chemical carcinogen by induction of the liver glutathione-S-transferase enzyme system (Lam, et al., 1994, Food Technol. 48:104-108).
Citrus fruit tissues and by-products of juice processing such as peels and molasses are sources of limonoid glucosides and citrus seeds contain high concentrations of both limonoid aglycones and glucosides. Limonoid agylycones in the fruit tissues gradually disappear during the late stages of fruit growth and maturation.
Thirty-eight limonoid aglycones have been isolated from Citrus. The limonoids are present in three different forms: the dilactone (I) is present as the open D-ring form (monolactone), the limonoate A-ring lactone (II) and the glucoside form (III). Only the monolactones and glucosides are present in fruit tissues. (Hasegawa S. et al., 1994, in Food Phytochemicals for Cancer Prevention I, eds M-T. Huang et al., American Chemical Society, 198-207).
Compound III is the predominant limonoid glucoside found in all juice samples. In orange juice it comprises 56% of the total limonoid glucosides present, while in grapefruit and lemon juices, it comprises an average of 63% to 66% respectively. Procedures for the extraction and isolation of both aglycones and glucosides have been established to obtain concentrated sources of various limonoids (Lam, L. K. T. et al., 1994, in Food Phytochemicals for Cancer Prevention, eds. M. Huang, T. Osawa, C. Ho and R. T. Rosen, ACS Symposium Series 546, p 209). The use of limonoids alone or in combination with a citrus flavonoid, tocotrienol, a cancer chemotherapeutic agent, or a combination of any one of these agents, has not been reported for the prevention and treatment of neoplastic diseases.
2.2. Citrus Flavonoids
Epidemiological studies have shown that flavonoids present in the Mediterranean diet may reduce the risk of death from coronary heart disease (Hertog, M. G. et al., 1993, Lancet: 342, 1007-1011). Soybean isoflavones for example, genistein, which is a minor component of soy protein preparations may have cholesterol-lowering effects (Kurowska, E. M. et al., 1990, J. Nutr. 120:831-836). The flavonoids present in citrus juices such as orange and grapefruit include, but are not limited to, hesperetin and naringenin respectively. The use of flavonoids from citrus juices alone or in combination with a citrus limonoid, tocotrienol, a cholesterol—lowering drug, or a combination of any one of these agents, has not been reported for the treatment of hypercholesterolemia.
5
7
3′
4′
HESPERETIN
OH
OH
OH
OCH
3
NARINGENIN
OH
OH
—
OH
The flavonoids preset in tangerine include, but are not limited to tangeretin or nobiletin. These flavonoids were found to inhibit growth of both estrogen receptor-negative (ER−) and positive (ER+) breast cancer cells in culture and act synergistically with tamoxifen and tocotrienols (Guthrie N. et al., 1996, Proc. Am. Inst. Cancer Res., Abs. #8).
5
6
7
8
4′
5′
TANGERETIN
OCH
3
OCH
3
OCH
3
OCH
3
OCH
3
—
NOBILETIN
OCH
3
OCH
3
OCH
3
OCH
3
OCH
3
OCH
3
2.3 Tocotrienols in Palm Oil
Tocotrienols are present in palm oil and are a form of vitamin E having an unsaturated side chain. They include, but are not limited to alpha-tocotrienol, gamma-tocotrienol or delta-tocotrienol.
R1
R2
R3
&agr;-tocotrienol
CH
3
CH
3
CH
3
&ggr;-tocotrienol
H
CH
3
CH
3
&dgr;-tocotrienol
H
H
CH
3
2.4. Cancer Growth and Chemotherapy
Cancer is a disease of inappropriate tissue accumulation. Chemotherapeutic agents share one characteristic: they are usually more effective in killing or damaging malignant cells than normal cells. However, the fact that they do harm normal cells indicates their potential for toxicity. Animal tumor investigations and human clinical trials have shown that drug combinations produce higher rates of objective response and longer survival than single agents. Combination drug therapy is, therefore, the basis for most chemotherapy employed at present (DeVita, V. T. et.al., 1995, Cancer 35:98).
Cancer treatment requires inhibitions of a variety of factors including tumor cell proliferation, metastatic dissemination of cancer cells to other parts of the body, invasion, tumor-induced neovascularization, and enhancement of host immunological responses and cytotoxicity. Conventional cancer chemotherapeutic agents have often been selected on the basis of their cytotoxicity to tumor cells. However, some anticancer agents have adverse effects on the patient's immune system. Thus it would be greatly advantageous if a cancer therapy or treatment could be developed that would afford non-cytotoxic protection against factors that might lead to progression of tumors.
Because hormone therapy as well as chemotherapy is effective in controlling advanced breast cancer, it has been used as an adjuvant to mastectomy in primary breast cancer. Patients with ER+ or ER− tumors benefit from adjuvant chemotherapy. However, tamoxifen used alone as an adjuvant to mastectomy for breast cancer shows benefit in extending disease-free and overall survival (Cummings, F. J. et al., 1985, Ann. Intern. Med. 103;324).
3. SUMMARY OF THE INVENTION
The present invention is directed to a method for the prevention and/or treatment of neoplastic diseases, which involves using a composition of citrus limonoids to treat an individual at high risk for, or suffering from cancer.
The present invention is also directed to a method for the prevention and/or treatment of breast cancer, which involves using a composition of citrus limonoids and citrus flavonoids to an individual at high risk or suffering from cancer.
The present invention is also directed to a method for the prevention and/or treatment of breast cancer, which involves using a composition of citrus limonoids, citrus flavonoids and tocotrienols to an individual at high risk or suffering from cancer.
The present invention is also directed to a method for the prevention and/or treatment of breast cancer, which involves using a composition of citrus limonoids, citrus fla
Carroll Kenneth Kitchener
Guthrie Najla
Kurowska Elzbieta Maria
KGK Synergize INC
Lankford , Jr. Leon B.
Tate Christopher R.
LandOfFree
Compositions and methods of treatment of neoplastic diseases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods of treatment of neoplastic diseases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of treatment of neoplastic diseases... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2449564